Comparison of the safety profiles between insulin mid mixture lispro mix 50 (LM50) and low mixture lispro mix 25 (LM25) as a starter insulin in Chinese patients with type 2 diabetes mellitus: a subgroup analysis of the CLASSIFY study
单位：[1]Department of endocrine and metabolism, Xin Hua Hospital affiliated to Shanghai Jiao Tong University School of Medicine[2]Medical department, Lilly Suzhou Pharmaceutical Co. Ltd[3]Department of endocrine and metabolism, Sino‐Japanese Friendship Hospital
第一作者单位：[1]Department of endocrine and metabolism, Xin Hua Hospital affiliated to Shanghai Jiao Tong University School of Medicine
推荐引用方式(GB/T 7714)：
Su Qing,Hou Jianing,Li Pengfei,et al.Comparison of the safety profiles between insulin mid mixture lispro mix 50 (LM50) and low mixture lispro mix 25 (LM25) as a starter insulin in Chinese patients with type 2 diabetes mellitus: a subgroup analysis of the CLASSIFY study[J].DIABETES-METABOLISM RESEARCH and REVIEWS.2017,33:
APA：
Su, Qing,Hou, Jianing,Li, Pengfei&Yang, Wenying.(2017).Comparison of the safety profiles between insulin mid mixture lispro mix 50 (LM50) and low mixture lispro mix 25 (LM25) as a starter insulin in Chinese patients with type 2 diabetes mellitus: a subgroup analysis of the CLASSIFY study.DIABETES-METABOLISM RESEARCH and REVIEWS,33,
MLA：
Su, Qing,et al."Comparison of the safety profiles between insulin mid mixture lispro mix 50 (LM50) and low mixture lispro mix 25 (LM25) as a starter insulin in Chinese patients with type 2 diabetes mellitus: a subgroup analysis of the CLASSIFY study".DIABETES-METABOLISM RESEARCH and REVIEWS 33.(2017)
：